A novel humanized antibody targeting CD39 that enhances anti-tumor immunity and the efficacy of cancer immunotherapy.

被引：0

作者：

Ban, Haruka ^{[1
]}

Obonai, Toshifumi ^{[1
]}

Mishima, Yuji ^{[1
]}

Matsumoto, Noriko ^{[1
]}

Mie, Motoya ^{[1
]}

Nakamura, Norihiro ^{[1
]}

机构：

[1] BrightPath Biotherapeut Co Ltd, Kawasaki, Kanagawa, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e14508

引用

页数：1

共 50 条

[21] CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models [J].

Lv, Zhuangwei ;

Zhang, Ping ;

Li, Dandan ;

Qin, Mengting ;

Nie, Longzhu ;

Wang, Xiaoqian ;

Ai, Li ;

Feng, Zhaozu ;

Odhiambo, Woodvine Otieno ;

Ma, Yunfeng ;

Ji, Yanhong .

ONCOIMMUNOLOGY, 2020, 9 (01)

[22] Inhibition of CD39 by AB598 enhances the effects of chemotherapy and anti-PD-1 therapy to promote myeloid cell and T cell anti-tumor immunity [J].

Jin, Ke ;

Clor, Julie ;

Stetson, L. C. ;

Fuchs, Rebecca ;

Cho, Sean ;

Singh, Jaskirat ;

Kaplan, Angelo ;

Peterson, Milene ;

Walters, Matthew ;

Fernandez-Salas, Ester ;

Bowman, Christine .

CANCER RESEARCH, 2025, 85 (08)

[23] A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity [J].

Shen, Kuan-Yin ;

Liu, Hsin-Yu ;

Li, Hui-Ju ;

Wu, Chiao-Chieh ;

Liou, Gunn-Guang ;

Chang, Yuan-Chih ;

Leng, Chih-Hsiang ;

Liu, Shih-Jen .

JOURNAL OF CONTROLLED RELEASE, 2016, 233 :57-63

[24] A novel role of master regulator transcription factor in anti-tumor immunity and cancer immunotherapy [J].

Sinha, Uttam K. ;

Lin, De-Chen .

THERANOSTICS, 2023, 13 (06) :1823-1825

[25] Targeting ALPPL2 with a novel CD89 bispecific antibody reprograms macrophages to enhance anti-tumor immunity [J].

Xu, Lijun ;

Yang, Bowen ;

Zhang, Junhan ;

Liu, Shujian ;

Zhang, Qi ;

Ran, Longchao ;

Li, Bingyu .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 762

[26] Enhancing the Efficacy of Anti-tumor Immunotherapy by Targeting T cell Metabolism [J].

Xin Pei Ji ;

Qiu Yan Liu .

JournalofNutritionalOncology, 2019, 4 (02) :67-73

[27] Specificity, biodistribution, tumor targeting, and pharmacokinetics of a novel humanized anti-Globo H antibody, OBI-888, for cancer immunotherapy [J].

Chen, Yu-Chi ;

Yang, Ming-Chen ;

Shia, Chi-Sheng ;

Tsao, Chun-Yen ;

Lai, Jiann-Shiun ;

Chen, I-Ju .

CANCER RESEARCH, 2019, 79 (13)

[28] CD200 expression on tumor cells suppresses anti-tumor immunity: New approaches to cancer immunotherapy [J].

Kretz-Rommel, Anke ;

Qin, Fenghua ;

Dakappagari, Naveen ;

McWhirter, John ;

Oltean, Daniela ;

Ravey, Edward Prenn ;

Wu, Dayang ;

Springhorn, Jeremy ;

Bowdish, Katherine S. .

JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) :666-666

[29] Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells [J].

Morita, Shinkichi ;

Mochizuki, Mai ;

Wada, Kouichi ;

Shibuya, Rie ;

Nakamura, Mao ;

Yamaguchi, Kazunori ;

Yamazaki, Tomoko ;

Imai, Takayuki ;

Asada, Yukinori ;

Matsuura, Kazuto ;

Sugamura, Kazuo ;

Katori, Yukio ;

Satoh, Kennichi ;

Tamai, Keiichi .

CANCER LETTERS, 2019, 461 :144-152

[30] Targeting shared hotspot cancer mutations with a Listeria monocytogenes immunotherapy induce potent anti-tumor immunity [J].

Villarreal, Daniel ;

Coder, Brandon ;

Armington, Susan ;

L'Huillier, Andrew ;

Mottershead, Cristina ;

Filippova, Elena ;

Thambi, Nithya ;

Ramos, Kim ;

Balli, David ;

Petit, Robert ;

Princiotta, Michael .

CANCER RESEARCH, 2018, 78 (13)

← 1 2 3 4 5 →